Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2003
06/05/2003US20030104400 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infammatory, immunol;ogical and nervous system disorders
06/05/2003US20030104088 Sulfated proteoglycan; one or more of a hexosamine sulfate,a flavone, olive kernel extract, S-adenosylmethionine, a histamine-1 receptor antagonist, a histamine-3 receptor agonist, an antagonist of CRH, caffeine, and a polyamine.
06/05/2003US20030104087 Proteoglycan compositions for treating arthritic inflammatory conditions
06/05/2003US20030104016 Reducing inflammation by topically applying totarol or an ester of totarol
06/05/2003US20030104006 Hyaluronidase activity and allergenic cell activity inhibitor
06/05/2003US20030103995 Detection and therapy of vulnerable plaque with photodynamic compounds
06/05/2003US20030103978 Antibodies and antigen binding domains used to prevent or treat conditions relating to loss of bone mass and bone disorders; nucleic acid encoding antibodies and antigen binding domains
06/05/2003US20030103954 Comprises vitamin D3 for regulating cell differentiation and/or cell proliferation
06/05/2003US20030103953 Comprises vitamin D3 for controlling cell differentiation and/or cell proliferation
06/05/2003US20030103942 Comprises recombinant adeno-associated virus vectors encoding TNF antagonist; antiinflammatory agents for connective tissues and joints
06/05/2003CA2468717A1 Aryl fused azapolycyclic compounds
06/05/2003CA2468706A1 Combination of an il-1/18 inhibitor with a tnf inhibitor for the treatment of inflammation
06/05/2003CA2468402A1 Ccr-3 receptor antagonists vii
06/05/2003CA2468256A1 Compositions comprising phenyl-glycine derivatives
06/05/2003CA2468253A1 Process for coating a surface of a stent
06/05/2003CA2468184A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003CA2468135A1 Ginger extract preparation
06/05/2003CA2468071A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003CA2468020A1 Osteopontin-related compositions and methods
06/05/2003CA2467892A1 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003CA2467647A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003CA2466870A1 Methods for treating autoimmune disorders, and reagents related thereto
06/05/2003CA2466863A1 Formulations for oral administration of cromolyn sodium
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2435758A1 Polynucleotide therapy_against autoantigens for treating insulin dependent diabetes mellitus
06/04/2003EP1316547A1 Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy -4(s)- n-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315812A2 Modified polypeptides stabilized in a desired conformation and methods for producing same
06/04/2003EP1315804A2 Novel mmp-2 derivatives for use as inhibitors of integrin alpha vbeta 3
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315793A1 Methods for culturing human lung mast cells and uses thereof
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315736A2 Nucleoside derivatives for the treatment of hepatitis c
06/04/2003EP1315735A1 Phosphate derivatives as immunoregulatory agents
06/04/2003EP1315727A2 7-oxo pyridopyrimidines
06/04/2003EP1315726A1 7- oxo pyridopyrimidines as inhibitors of cellular proliferation
06/04/2003EP1315725A1 Bicyclic enamide derivatives being integrin inhibitors
06/04/2003EP1315718A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315717A1 Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315694A2 Inhibitors of alpha 4 mediated cell adhesion
06/04/2003EP1315513A2 "pseudo"-native chemical ligation
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1315511A2 Synthetic erythropoiesis stimulating proteins
06/04/2003EP1315504A1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
06/04/2003EP1315501A1 Alpha v integrin receptor antagonists
06/04/2003EP1315500A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
06/04/2003EP1315496A2 The treatment of inflammatory disorders
06/04/2003EP1315482A2 Water-dispersible encapsulated sterols
06/04/2003EP1216046B1 Novel combination of loteprednol and antihistamines
06/04/2003EP1214347B1 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
06/04/2003EP1200088B1 Paracetamol and drotaverine containing composition
06/04/2003EP1143928B1 Milling process for the production of finely milled medicinal substances
06/04/2003EP1105390B1 Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases
06/04/2003EP1075476B1 Novel benzimidazoles and benzoxazoles
06/04/2003EP0968180B1 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase ii
06/04/2003EP0966439B1 Certain cyclic thio substituted acylaminoacid amide derivatives
06/04/2003EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0938496B1 Heptapeptide oxytocin analogues
06/04/2003EP0927031B1 Pharmaceutical preparation containing nimesulide for oral administration
06/04/2003EP0920869B1 Stable external preparations containing acetylsalicylic acid
06/04/2003EP0858329B1 Novel stable liquid paracetamol compositions, and method for preparing same
06/04/2003EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors
06/04/2003EP0775118B1 Benzimidazole derivatives having dopaminergic activity
06/04/2003CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
06/04/2003CN1422271A Pyrrolopyrimidinone derivatives, process of preparation and use
06/04/2003CN1422269A 1H-imidazopyridine derivatives
06/04/2003CN1422263A Estrogen agonist/antagonist metabolites
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422254A Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
06/04/2003CN1422253A Carbamate caspase inhibitors and uses thereof
06/04/2003CN1422157A Divided dose therapies with vascular damaging activity
06/04/2003CN1421236A Externally applied medicated wine for treating ischias and its making process
06/04/2003CN1421235A Externally applied medicated wine for treating arthritis and its making process
06/04/2003CN1421233A Compound pain-stopping and inflammation-diminishing anticarcinogen capsule
06/04/2003CN1421230A Granulation promoting and pus drawing out ointment
06/04/2003CN1110499C Spiro-quinuclidine derivatives, their preparation and use
06/04/2003CN1110495C Arylalkyl diazinones, its preparing method and its medical preparation
06/04/2003CN1110488C 2-(3H)-oxazolene derivatives and their use as cox-2 inhibitors
06/04/2003CN1110484C 2-(cary lphenyl) amino-imidazoline derivatives
06/04/2003CN1110482C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
06/03/2003US6573390 Muscle relaxant, hypotensive agent, respiratory system disorders, gastrointestinal disorders, fertility, incontinence, shock, antiinflammatory agents, immunology, bone disorders, antiproliferative agents
06/03/2003US6573362 Of given amino acid sequence; binding inhibition; can use in reducing or influencing inflammations, improving wound healing, suppressing theimmune system for organ transplants, preventing metastasis of tumors and treating arteriosclerosis
06/03/2003US6573295 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
06/03/2003US6573293 Anticancer agents
06/03/2003US6573285 Method for preventing or treating pain by administering an endothelin antagonist
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
06/03/2003US6573266 Piperazine derivatives and their use as anti-inflammatory agents
06/03/2003US6573259 Inhibitors of interleukin-1β converting enzyme
06/03/2003US6573255 Vitamin D analogues
06/03/2003US6573246 Modified ether glyceroglycolipids
06/03/2003US6573095 Polynucleotides isolated from skin cells
06/03/2003US6573067 Nucleic acid encoding sodium channels in dorsal root ganglia
06/03/2003US6572858 Uses for anti-malarial therapeutic agents
06/03/2003US6572855 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation
06/03/2003US6572854 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
06/03/2003US6572638 Method of controlling body temperature while inhibiting thermoregulatory responses
1 ... 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 ... 1272